Filter
2613
Filtered Results: 2613
Text search:
efficacy
of
medicines
Featured
Recommendations
277
New Publications
600
Language
Document type
No document type
1355
Guidelines
513
Studies & Reports
420
Manuals
124
Strategic & Response Plan
80
Fact sheets
45
Training Material
39
Situation Updates
14
Resource Platforms
8
Infographics
7
Brochures
5
Videos
2
Online Courses
1
Countries / Regions
Global
104
India
97
South Africa
67
Kenya
61
Uganda
50
Ethiopia
46
Western and Central Europe
44
Africa
40
Tanzania
39
Zambia
37
Nigeria
36
Latin America and the Carribbean
33
Liberia
32
Sierra Leone
31
Rwanda
30
Nepal
27
Ghana
26
Malawi
26
Congo, Democratic Republic of
24
Bangladesh
24
Russia
22
Philippines
19
Zimbabwe
18
South–East Asia Region
18
Eastern Europe
18
Myanmar / Burma
17
Ukraine
16
Senegal
16
West and Central Africa
16
Brazil
16
Namibia
16
Indonesia
16
Burkina Faso
15
Mozambique
15
Cameroon
14
East and Southern Africa
14
Lesotho
12
Guinea
12
Cambodia
11
Germany
10
Eswatini/ Swaziland
10
Haiti
9
Asia
9
Botswana
9
Benin
8
Pakistan
8
Syria
6
Laos
6
Peru
6
USA
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
North America
6
Sri Lanka
6
Sudan
6
Afghanistan
5
Côte d’Ivoire / Ivory Coast
5
Vietnam
5
South Sudan
5
Thailand
4
Western Pacific Region
4
United Kingdom
4
Lebanon
4
Mali
4
Angola
4
China
3
Chile
3
Niger
3
Venezuela
3
Jordan
3
Paraguay
3
France
3
Argentina
3
Georgia
3
Chad
3
Bhutan
3
Somalia
3
Madagascar
3
Colombia
2
Turkey
2
Iran
2
Albania
2
Morocco
2
Guinea-Bissau
2
Gabon
2
Tunisia
2
Spain
2
Yemen
2
Iraq
2
Ecuador
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Mexico
1
Australia
1
Togo
1
Canada
1
Fiji
1
Singapore
1
Congo-Brazzaville
1
Burundi
1
Qatar
1
Italy
1
Saudi Arabia
1
Denmark
1
Mauritius
1
Papua New Guinea
1
Greece
1
Central African Republic
1
Libya
1
Authors & Publishers
Publication Years
Category
Countries
844
Clinical Guidelines
336
Public Health
174
Women & Child Health
117
Key Resources
63
Capacity Building
37
Pharmacy & Technologies
35
Toolboxes
COVID-19
261
Mental Health
259
HIV
220
TB
173
AMR
151
NTDs
137
Pharmacy
123
Rapid Response
68
Ebola & Marburg
68
NCDs
67
Caregiver
62
Disability
47
Planetary Health
38
Refugee
23
Conflict
14
Global Health Education
14
Health Financing Toolbox
12
Malaria
10
Zika
9
Cholera
8
Polio
8
Natural Hazards
6
Specific Hazards
4
Social Ethics
4
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; and alcohol and opioid dependence
The document contains a set of indicators that can be used for monitoring traditional and complementary medicine (T&CM) systems in a country.
The core indicator set consists of 16 indicators that were considered essential and collectively able to provide information on T&CM inputs, processes and ou...
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous preparation’.
The guidance should be read alon...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
Full eHandbook under: http://www.msh.org/resources/health-systems-in-action-an-ehandbook-for-leaders-and-managers
Effective supply management has the potential to make a powerful contribution to the reliable availability of essential medicines, which are a crucial part of the delivery of highqualit...
For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has also been increased attention given to the safety and efficacy of “re-purposed” drugs that have been widely used to treat other infections but are al...
Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe) classification could facilitate simple stewardship interventions that are widely applicable globally....
Recommandations francaises pour la prise enc harge du chikungunya
Médecine e tmaladies infectieuses 45(2015)243–263
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
In this edition, medicines used in ICU, haemodialysis and chemotherapy unit has also been added under NEML. The medicines under disinfectants and antiseptics, intrauterine devices and barrier methods under contraceptives has been deleted and moved to medical supplies and equipment list. A section...
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
Severe Acute Malnutrition (SAM) is one of the greatest child survival challenges in the world today and
reportedly affects more than 16.2 million children each year1. High impact, proven treatment interventions exist
yet sadly approximately only 3.2 million children with SAM have access to treatme...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac...
Replacement of Annex 2 of WHO Technical Report Series, No. 964...
